| Year |
Citation |
Score |
| 2007 |
Guo J, Parise RA, Joseph E, Lan J, Pan SS, Joo B, Egorin MJ, Wipf P, Lazo JS, Eiseman JL. Pharmacology and antitumor activity of a quinolinedione Cdc25 phosphatase inhibitor DA3003-1 (NSC 663284). Anticancer Research. 27: 3067-73. PMID 17970046 |
0.404 |
|
| 2007 |
Brisson M, Foster C, Wipf P, Joo B, Tomko RJ, Nguyen T, Lazo JS. Independent mechanistic inhibition of cdc25 phosphatases by a natural product caulibugulone. Molecular Pharmacology. 71: 184-92. PMID 17018577 DOI: 10.1124/Mol.106.028589 |
0.494 |
|
| 2005 |
Brisson M, Nguyen T, Wipf P, Joo B, Day BW, Skoko JS, Schreiber EM, Foster C, Bansal P, Lazo JS. Redox regulation of Cdc25B by cell-active quinolinediones. Molecular Pharmacology. 68: 1810-20. PMID 16155209 DOI: 10.1124/Mol.105.016360 |
0.5 |
|
| 2004 |
Wipf P, Joo B, Nguyen T, Lazo JS. Synthesis and biological evaluation of caulibugulones A-E. Organic & Biomolecular Chemistry. 2: 2173-4. PMID 15280951 DOI: 10.1039/B408184F |
0.431 |
|
| 2002 |
Lazo JS, Nemoto K, Pestell KE, Cooley K, Southwick EC, Mitchell DA, Furey W, Gussio R, Zaharevitz DW, Joo B, Wipf P. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors. Molecular Pharmacology. 61: 720-8. PMID 11901209 DOI: 10.1124/Mol.61.4.720 |
0.525 |
|
| 2001 |
Lazo JS, Aslan DC, Southwick EC, Cooley KA, Ducruet AP, Joo B, Vogt A, Wipf P. Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. Journal of Medicinal Chemistry. 44: 4042-9. PMID 11708908 DOI: 10.1021/Jm0102046 |
0.508 |
|
| Show low-probability matches. |